TGF-β signaling in the lungs is strictly controlled, and abnormal expression of TGF-β can provoke phenotypic and functional changes in the airway SMCs (ASMCs), which can lead to the development of asthma and other lung diseases [62]. The gene discussed is TGFB1; the disease is asthma.